These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 37559999)
1. Autotaxin production in the human breast cancer tumor microenvironment mitigates tumor progression in early breast cancers. Benesch MG; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K Am J Cancer Res; 2023; 13(7):2790-2813. PubMed ID: 37559999 [TBL] [Abstract][Full Text] [Related]
2. Insights into autotaxin- and lysophosphatidate-mediated signaling in the pancreatic ductal adenocarcinoma tumor microenvironment: a survey of pathway gene expression. Benesch MG; Wu R; Rog CJ; Brindley DN; Ishikawa T; Takabe K Am J Cancer Res; 2024; 14(8):4004-4027. PubMed ID: 39267662 [TBL] [Abstract][Full Text] [Related]
3. Decreased Lipid Phosphate Phosphatase 1/3 and Increased Lipid Phosphate Phosphatase 2 Expression in the Human Breast Cancer Tumor Microenvironment Promotes Tumor Progression and Immune System Evasion. Benesch MGK; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190226 [TBL] [Abstract][Full Text] [Related]
4. High Nelson ED; Benesch MG; Wu R; Ishikawa T; Takabe K Am J Cancer Res; 2024; 14(1):227-242. PubMed ID: 38323277 [TBL] [Abstract][Full Text] [Related]
5. Tumor-induced inflammation in mammary adipose tissue stimulates a vicious cycle of autotaxin expression and breast cancer progression. Benesch MG; Tang X; Dewald J; Dong WF; Mackey JR; Hemmings DG; McMullen TP; Brindley DN FASEB J; 2015 Sep; 29(9):3990-4000. PubMed ID: 26071407 [TBL] [Abstract][Full Text] [Related]
6. Role of Adipose Tissue-Derived Autotaxin, Lysophosphatidate Signaling, and Inflammation in the Progression and Treatment of Breast Cancer. Brindley DN; Tang X; Meng G; Benesch MGK Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824846 [TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic Acid Receptor Signaling in the Human Breast Cancer Tumor Microenvironment Elicits Receptor-Dependent Effects on Tumor Progression. Benesch MGK; Wu R; Tang X; Brindley DN; Ishikawa T; Takabe K Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37372960 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironment. Wu R; Sarkar J; Tokumaru Y; Takabe Y; Oshi M; Asaoka M; Yan L; Ishikawa T; Takabe K Am J Cancer Res; 2022; 12(2):504-520. PubMed ID: 35261783 [TBL] [Abstract][Full Text] [Related]
9. Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts. David M; Wannecq E; Descotes F; Jansen S; Deux B; Ribeiro J; Serre CM; Grès S; Bendriss-Vermare N; Bollen M; Saez S; Aoki J; Saulnier-Blache JS; Clézardin P; Peyruchaud O PLoS One; 2010 Mar; 5(3):e9741. PubMed ID: 20305819 [TBL] [Abstract][Full Text] [Related]
10. Implications for breast cancer treatment from increased autotaxin production in adipose tissue after radiotherapy. Meng G; Tang X; Yang Z; Benesch MGK; Marshall A; Murray D; Hemmings DG; Wuest F; McMullen TPW; Brindley DN FASEB J; 2017 Sep; 31(9):4064-4077. PubMed ID: 28539367 [TBL] [Abstract][Full Text] [Related]
11. Autotaxin and Lysophosphatidate Signaling: Prime Targets for Mitigating Therapy Resistance in Breast Cancer. Benesch MGK; Tang X; Brindley DN; Takabe K World J Oncol; 2024 Feb; 15(1):1-13. PubMed ID: 38274724 [TBL] [Abstract][Full Text] [Related]
12. Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer. Meng G; Tang X; Yang Z; Zhao Y; Curtis JM; McMullen TPW; Brindley DN FASEB J; 2019 Feb; 33(2):1899-1910. PubMed ID: 30192654 [TBL] [Abstract][Full Text] [Related]
13. Infliximab, a Monoclonal Antibody against TNF-α, Inhibits NF-κB Activation, Autotaxin Expression and Breast Cancer Metastasis to Lungs. Shinde A; Tang X; Singh R; Brindley DN Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201482 [TBL] [Abstract][Full Text] [Related]
14. ADSCs and adipocytes are the main producers in the autotaxin-lysophosphatidic acid axis of breast cancer and healthy mammary tissue in vitro. Schmid R; Wolf K; Robering JW; Strauß S; Strissel PL; Strick R; Rübner M; Fasching PA; Horch RE; Kremer AE; Boos AM; Weigand A BMC Cancer; 2018 Dec; 18(1):1273. PubMed ID: 30567518 [TBL] [Abstract][Full Text] [Related]
16. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate. Benesch MG; Zhao YY; Curtis JM; McMullen TP; Brindley DN J Lipid Res; 2015 Jun; 56(6):1134-44. PubMed ID: 25896349 [TBL] [Abstract][Full Text] [Related]
17. Autotaxin Inhibition with IOA-289 Decreases Breast Tumor Growth in Mice Whereas Knockout of Autotaxin in Adipocytes Does Not. Tang X; Morris AJ; Deken MA; Brindley DN Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296899 [TBL] [Abstract][Full Text] [Related]
18. Roles of Autotaxin/Autotaxin-Lysophosphatidic Acid Axis in the Initiation and Progression of Liver Cancer. She S; Zhang Q; Shi J; Yang F; Dai K Front Oncol; 2022; 12():922945. PubMed ID: 35769713 [TBL] [Abstract][Full Text] [Related]
19. KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival. Tokumaru Y; Oshi M; Katsuta E; Yan L; Satyananda V; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K Am J Cancer Res; 2020; 10(3):897-907. PubMed ID: 32266098 [TBL] [Abstract][Full Text] [Related]
20. The Expression Regulation and Biological Function of Autotaxin. Zhang X; Li M; Yin N; Zhang J Cells; 2021 Apr; 10(4):. PubMed ID: 33921676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]